Nordicus Partners Corp. Files 8-K: Material Agreement & Equity Update
Ticker: NORD · Form: 8-K · Filed: Sep 19, 2025 · CIK: 1011060
Sentiment: neutral
Topics: material-agreement, equity-sale, filing-update
TL;DR
Nordicus Partners Corp. signed a big deal and sold some stock, filing it all today.
AI Summary
Nordicus Partners Corp. entered into a Material Definitive Agreement on September 18, 2025. The company also reported on Unregistered Sales of Equity Securities and filed Financial Statements and Exhibits. The filing was made on September 19, 2025.
Why It Matters
This 8-K filing indicates significant corporate activity, including a new material agreement and potential equity transactions, which could impact the company's future financial performance and strategic direction.
Risk Assessment
Risk Level: medium — The filing mentions a 'Material Definitive Agreement' and 'Unregistered Sales of Equity Securities,' which could represent significant changes or risks for the company.
Key Players & Entities
- Nordicus Partners Corp. (company) — Registrant
- EKIMAS Corp (company) — Former company name
- AdvanSource Biomaterials Corp (company) — Former company name
- CARDIOTECH INTERNATIONAL INC (company) — Former company name
FAQ
What is the nature of the Material Definitive Agreement entered into by Nordicus Partners Corp. on September 18, 2025?
The filing does not specify the details of the Material Definitive Agreement, only that one was entered into on September 18, 2025.
What type of equity securities were sold in the unregistered sales reported by Nordicus Partners Corp.?
The filing mentions 'Unregistered Sales of Equity Securities' but does not provide specific details about the type or amount of securities sold.
When was Nordicus Partners Corp. incorporated, and in which state?
Nordicus Partners Corp. was incorporated in Delaware.
What is the fiscal year end for Nordicus Partners Corp.?
The fiscal year end for Nordicus Partners Corp. is March 31.
What were Nordicus Partners Corp.'s former company names?
Nordicus Partners Corp. was formerly known as EKIMAS Corp, AdvanSource Biomaterials Corp, and CARDIOTECH INTERNATIONAL INC.
Filing Stats: 831 words · 3 min read · ~3 pages · Grade level 12.6 · Accepted 2025-09-18 19:59:29
Key Financial Figures
- $0.01 — d shares of our common stock, par value $0.01 per share. The price per share was $1.9
- $1.90 — 0.01 per share. The price per share was $1.90. On September 18, 2025 we determined to
Filing Documents
- form8-k.htm (8-K) — 41KB
- 0001493152-25-014113.txt ( ) — 199KB
- nord-20250919.xsd (EX-101.SCH) — 3KB
- nord-20250919_lab.xml (EX-101.LAB) — 33KB
- nord-20250919_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Dated: September 18, 2025 Nordicus Partners Corporation By: /s/ Henrik Rouf Henrik Rouf Chief Executive Officer